me/cfs

  1. Nightsong

    Expert perspectives on [ME/CFS] – Insights from the 3rd International Conference of the Charité Fatigue Center, 2026, Fehrer et al

    Abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystemic disorder mostly triggered by viral infections, with core symptoms including post-exertional malaise (PEM), fatigue, pain, and cognitive dysfunction. Its prevalence has increased significantly in the...
  2. B

    Open Causal mechanisms in fatigue, Morten & Williams [England]

    Not quite sure where to put this. MEA promoting a study focussed on just fatigue in ME/CFS and Long Covid lumped together is a little concerning. never mind the requirement to travel to Oxford to do it which will select the mildest patients for a lengthy appointment to measure brain waves...
  3. forestglip

    [Abstract] Persistent class switch toward spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination in [PAIS ...], 2026, Espino et al

    Persistent class switch toward spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination in post-acute infection syndrome: an exploratory cohort study Ana M. Espino, Carlimar Ocasio-Malavé, Riseilly Ramos, Ramon Sanmartin, Jesus Castro-Marrero Abstract Myalgic...
  4. Nightsong

    Incidence age is bimodal for [ME/CFS], with higher severity burden for early onset disease, 2026, McGrath et al

    Abstract: Myalgic Encephalomyelitis, or Chronic Fatigue Syndrome (ME/CFS), is a disease of uncertain origin. Studies of Norwegian health records have suggested that ME/CFS incidence across age groups is bimodal–a characteristic that could provide insight into the aetiology of the disease. Here...
  5. forestglip

    Intersectionality, healthcare and myalgic encephalomyelitis: Reflections from experience, 2026, Hunt et al

    Intersectionality, healthcare and myalgic encephalomyelitis: Reflections from experience Hunt, Joanne Abstract Healthcare practice and policy impacting disabled groups has historically reduced disability to an individual phenomenon and homogenised experiences of disability. Such practices –...
  6. forestglip

    Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach [..] recovery, 2026, Abrahamsen+

    Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery Background A substantial proportion of people consulting primary care practitioners have symptoms that persist even after structural problems and diseases...
  7. forestglip

    Thesis “It’s like a superpower of ‘look how amazing I can do this’, but then you are dead”: [...] exploring ME/CFS and ADHD multimorbidity, 2026, Snell

    “It’s like a superpower of ‘look how amazing I can do this’, but then you are dead”: An interpretative phenomenological approach exploring ME/CFS and ADHD multimorbidity Gracie Snell Objective This study explores the lived experience of individuals diagnosed with multimorbid Myalgic...
  8. forestglip

    Prevalence and Patterns of [GWI] in Kansas Veterans: Association of Symptoms with Characteristics [...] of Military Service, 2000, Steele

    Prevalence and Patterns of Gulf War Illness in Kansas Veterans: Association of Symptoms with Characteristics of Person, Place, and Time of Military Service Steele, L. Abstract Gulf War veterans have reported health problems that they attribute to their military service, but little is...
  9. forestglip

    Pipeline-optimized machine learning for [CFS] diagnosis: A lightweight, interpretable model using blood biochemical and metabolomic data, 2026, Li+

    Pipeline-optimized machine learning for chronic fatigue syndrome diagnosis: A lightweight, interpretable model using blood biochemical and metabolomic data [Line breaks added] Introduction and Background Chronic fatigue syndrome (CFS) is a debilitating multisystem disorder with persistent...
  10. forestglip

    Extracellular Vesicle Protein and MiRNA Signatures as Biomarkers for Post-Infectious ME/CFS Patients, 2026, Seifert et al

    Extracellular Vesicle Protein and MiRNA Signatures as Biomarkers for Post-Infectious ME/CFS Patients [Line breaks added] Abstract Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic disease with unresolved pathophysiology and limited diagnostic options...
  11. Nightsong

    Assessment and Incidence Determination of [ME/CFS] Following a SARS-CoV-2 Infection in a Prospective Cohort, 2026, Tack et al

    Background and Objectives: Post-COVID-19 syndrome (PCS), characterized by persistent fatigue, can develop after a SARS-CoV-2 infection. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, post-infectious condition marked by severe fatigue and post-exertional malaise. This...
  12. Kalliope

    Norway: 2026 Guidelines for chronic fatigue and ME/CFS - draft published

    The draft has now been published online. https://www.helsedirektoratet.no/retningslinjer/utmattelse-langvarig-utmattelse-inkl.me-cfs-horingsutkast For comment on the development of the guidelines, see Norway: 2025-2026 Chronic Fatigue and ME/CFS Guidelines - Development
  13. forestglip

    Who receives a diagnostic label for fibromyalgia, [CFS], and irritable bowel syndrome? A study in the lifelines cohort, 2026, Tattan et al

    Who receives a diagnostic label for fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome? A study in the lifelines cohort Tattan, Mais; Hanssen, Denise J.C.; Rosmalen, Judith G.M. Highlights • Only 25% with FM, 14% with CFS, and 48% with IBS received a formal diagnosis...
  14. John Mac

    Preprint In Search of Lost Volume: The Potential Causes of Hypovolemia in ME/CFS, 2026, Wirth

    https://www.preprints.org/frontend/manuscript/83de3b17750c8bef6d571f548f84b5e8/download_pub Abstract Hypovolemia and orthostatic intolerance are hallmark features of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) but remain incompletely understood. This review summarizes the...
  15. forestglip

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report Donnellan, Patricia Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition with no consistently effective treatment. The mineralocorticoid receptor variant...
  16. ahimsa

    The Boston Globe: A doctor watches his 28-year-old daughter suffer from long COVID. He clings fiercely to hope.

    Paywall link: https://www.bostonglobe.com/2026/02/20/metro/long-covid-young-woman-treatment/ Archive link: https://archive.is/uJjel#selection-1173.0-1173.74
  17. John Mac

    The evolving science of Long COVID and its far-reaching economic and social impacts, 2026, Emily Taylor, CEO SolveME

    Emily Taylor, President and Chief Executive Officer of Solve M.E., discusses the significant socioeconomic burden of Long COVID, highlighting advances in research that can improve understanding of Long COVID and enable targeted interventions and better treatment protocols Long COVID is an...
  18. forestglip

    Still to open [Houston, Texas, USA] Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort (ViTAL-SCAN19)

    Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort (ViTAL-SCAN19) Brief Summary The goal of this clinical trial is to evaluate whether metabolic modulation with a combined nutraceutical product can improve symptoms and metabolic health in adults...
  19. John Mac

    Trial Report Vitamin D in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome after COVID-19 or Vaccination: A Randomized Controlled Trial, 2026, Kodama et al

    Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) can develop as post-vaccination syndrome (PVS) or Post-Acute Sequelae of SARS-CoV-2 infection (PASC). In our prior retrospective study, most patients with PVS who developed ME/CFS had vitamin D insufficiency or...
  20. John Mac

    Review POTS, ME/CFS and Long COVID as Neuroimmune Disorders, 2026, Blitshteyn et al

    Full title: Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders Abstract: Postural orthostatic tachycardia syndrome (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID are...
Back
Top Bottom